Source: International Congress 2018 – Tuberculosis comorbidities
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. F B Afonso (Vila Real, Portugal), F. Ferro (Lisboa, Portugal), J. Carvalho (Lisboa, Portugal), A. Cysneiros (Lisboa, Portugal), A. Tavares E Castro (Lisboa, Portugal), T. Mourato (Lisboa, Portugal), A. C Gomes (Lisboa, Portugal), C. Gomes (Lisboa, Portugal). Tuberculosis in the very elderly – clinical presentation and treatment outcomes. 2723

Member's Comments

No comment yet.

Related content which might interest you: Tuberculosis in the elderly: clinical presentation and outcome Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Clinical characteristics and treatment outcomes of tuberculosis in the elderly Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Clinical presentation and mortality of tuberculosis in the elderly Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Clinical management improves the treatment outcome of MDR-TB patients Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017 Tuberculosis in the elderly. Clinical aspects and outcomes. Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease Year: 2021 Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Predictors of defaulting from treatment among patients with tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of MDR-TB patients managed in a Nigerian tertiary hospital Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Diagnostic modalities and treatment outcome of tuberculous cervical lymphadenitis (TCL) – Retrospective study in a resource poor setting Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Could side effects of MDR-TB treatment change the outcome of the disease? Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Management of sarcoidosis in clinical practice Source: Eur Respir Rev 2016; 25: 141-150 Year: 2016 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Tuberculosis sequelae assessment and rehabilitation Source: Eur Respir Monogr 2018; 82: 326-342 Year: 2018 How can we improve the management and outcome of pneumonia in the elderly? Source: Eur Respir J 2008; 32: 12-14 Year: 2008 Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment Source: International Congress 2015 – Latent TB infection and screening Year: 2015